In order to obtain this action we must pay 5,87$ right now, Pluristem Therapeutics Inc is a company created in Israel dedicated to Biotechnology: Biological Products (No Diagnostic Substances) with its highest number of sales in Middle East. Its Executives are Chen Franco-Yehuda (Chief Financial Officer, Secretary & Treasurer), Lior Raviv (Vice President-Operations & Development), Nitsan Halevy (Chief Medical Officer), Racheli Ofir (Vice President-Research & Intellectual Property), Yaky Yanay (President, Chief Executive Officer & Director) and its address is MATAM ADVANCED TECHNOLOGY PARK BUILDING NO.5, HAIFA, 3508409, Israel.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 5,86$ moving between 5,75$ and 5,97$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
